Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

The method accurately and quickly measures silodosin and dutasteride in mixtures.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

CTP-543 is generally safe for treating alopecia areata.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Bicalutamide improves hair density in women safely.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

The drug combination was safe and showed promise in treating advanced tumors.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.